Primary Isoniazid Mono-Resistant Pulmonary Tuberculosis in a COVID-19-Positive Male: World's First Case of Its Kind in the Present Pandemic
- PMID: 36017273
- PMCID: PMC9393323
- DOI: 10.7759/cureus.27163
Primary Isoniazid Mono-Resistant Pulmonary Tuberculosis in a COVID-19-Positive Male: World's First Case of Its Kind in the Present Pandemic
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has resulted in numerous rare presentations of common diseases. The diseases that were prevalent for a long time like tuberculosis (TB) have been reported in cases of COVID-19. The reports of drug-sensitive, multidrug-resistant, and pre-extensively drug-resistant TB with COVID-19 are available in the medical literature. The situation in high TB burden countries where TB is a great contributor to morbidity and mortality is grisly. Herein, a case of primary isoniazid mono-resistant pulmonary tuberculosis in a COVID-19-positive Indian male is reported. As far as the literature is concerned, no case similar to our index case is ever reported.
Keywords: covid-19; isoniazid; rifampicin; rtpcr; tuberculosis.
Copyright © 2022, Yadav et al.
Conflict of interest statement
The authors have declared that no competing interests exist.
Figures
References
-
- Tuberculosis. [ Jul; 2022 ];https://www.who.int/news-room/fact-sheets/detail/tuberculosis 2021
-
- Global tuberculosis report 2021. [ Jul; 2022 ];https://www.who.int/publications/digital/global-tuberculosis-report-2021 Report. 2022
-
- India TB report 2022. [ Jul; 2022 ];https://tbcindia.gov.in/WriteReadData/IndiaTBReport2022/TBAnnaulReport20... 2022
Publication types
LinkOut - more resources
Full Text Sources
Research Materials